Abstract:Drug-eluting stents (DESs) can effectively control the harmful effects of coronary artery disease, because of their excellent ability to reduce in-stent restenosis. However, delayed re-endothelialization and late stent thrombosis have caused concern over the safety of DESs. In this study, according to time-ordered pathological responses after stent implantation, a hierarchical multiple drug-eluting stent was designed and prepared to overcome the existing DES limitations. A platelet membrane glycoprotein IIIa monoclonal antibody (SZ-21) and a vascular endothelial growth factor (VEGF(121)) were loaded into the inner coating of 316L stainless steel (316L SS) stents to inhibit thrombosis and promote re-endothelialization; rapamycin (RAPA) was loaded into the third layer to inhibit intima hyperplasia; a drug-free poly-L-lactic acid coating was located on the second and fourth layers and used as sustained release layers. The results showed that the three drugs exhibited sequential release kinetics without significant burst release. RAPA released quickly at the early stage, while SZ-21 and VEGF121 achieved a slow and prolonged release. In vitro experiments showed that the stents had excellent hemocompatibility and anti-inflammatory properties, and promoted the proliferation and migration of endothelial cells while inhibiting the proliferation and migration of smooth muscle cells. Finally the stents were implanted in the carotid arteries of New Zealand white rabbits. In vivo results showed that compared to 316L SS stents, the multiple drug-eluting stents could accelerate re-endothelialization and inhibit thrombosis, inflammation and in-stent restenosis after 4 weeks (12.79 +/- 2.45% vs. 25.27 +/- 4.81%) and 12 weeks (15.87 +/- 3.62% vs. 58.84 +/- 6.87%). These results indicate that the novel drug-eluting stent with multiple layer coatings will have a highly potential clinical application.

Numerical Study on the Effects of Drug Release Profile of Two Drug -eluting Stents on the Drug Concentration within the Vessel Wall

Numerical analysis of effects from drug - eluting stent height on drug concentration and wall shear stress distribution

Numerical Study on Effects of Drug-coating Position of Drug-eluting Stents on Drug Concentration

Numerical Simulation on the Effects of Drug Eluting Stents at Different Reynolds Numbers on Hemodynamic and Drug Concentration Distribution

Drug Release Kinetics from a Drug-Eluting Stent with Asymmetrical Coat.

A quantitative study of the effects of a dual layer coating drug-eluting stent on safety and efficacy

NUMERICAL STUDY ON THE EFFECTS OF THE NUMBER AND GEOMETRIES OF DRUG-ELUTING STENT LINKS ON THE DRUG CONCENTRATION

Numerical Investigation of Effects of Drug-eluting Stent Link on Flow Field and Concentration Field of Hemoynamics

A NEW WAY TO OPTIMIZE DRUG RELEASE RATE OF DRUG ELUTING STENT (DES)

Drug Release Analysis and Optimization for Drug-Eluting Stents

Numerical Simulation of Local Pharmacokinetics of a Drug after Intravascular Delivery with an Eluting Stent

Drug concentration and wall shear stress distribution in curved coronary artery with drug-eluting stents

Preparation and in Vitro Release Profiles of Drug-Eluting Controlled Biodegradable Polymer Coating Stents

The Design and Pharmacokinetics in Vivo of Rapamycin-PLGA Membrane Eluting Stent

Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.

Numerical Analysis on Drug Deposition from Drug-Eluting Stents in Curved Artery

Numerical Analysis of Effects from Atherosclerotic Plaque on Drug Diffusion in Drug-Eluting Stent

Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects

NUMERICAL ANALYSIS OF THE IMPACT OF ATHEROSCLEROTIC PLAQUE AND DIFFERENT STENT SPACING ON DRUG DEPOSITION

An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents

In Vitro Release Study of Sirolimus from a PDLLA Matrix on a Bioresorbable Drug-Eluting Stent